CervoMed CRVO
NASDAQ CRVO
$2.29 -0.02 (-0.87%)
At close: Oct 20, 2026 · 4:00 PM EDT

CervoMed (CRVO) Change in Other Operating Liabilities (2023 - 2024)

Updated

Analysis

CervoMed (CRVO) Change in Other Operating Liabilities (2023 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Liabilities Change (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn -
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn -972.00 Mn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn -
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn -
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn -32.00 Mn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -112.00 Mn
10 CervoMed 23.87 Mn -62.15 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 -1.40 Mn
Jun 30, 2024 829,026.00
Mar 31, 2024 572,475.00
Sep 30, 2023 -622,171.00
Jun 30, 2023 667,401.00
Mar 31, 2023 501,821.00
API Access

CervoMed Change in Other Operating Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-liabilities&ticker=CRVO&period=max&api_key=YOUR_API_KEY